Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man.
In this study we investigated the effect of selective (M1) and non-selective (M1 and M2) pharmacologic blockade of muscarinic receptors on cholecystokinin-induced gallbladder emptying. After validating the method of study, the gallbladder function was evaluated in 15 normal volunteers by quantitative biliary scintigraphy, and the effect of intravenous atropine (0.15 mg/10 kg) and pirenzepine (10 mg) was analyzed in each subject. Atropine significantly reduced the ejection period and the ejection fraction of gallbladder evacuation. Pirenzepine reduced the ejection period, but the ejection fraction remained unchanged. We conclude that the effect of cholecystokinin on gallbladder motility is mediated through muscarinic receptors. Our results suggest that M2 receptors, but not M1 receptors, are involved in this response.
Garrigues
V
V
Gastroenterology Unit, Hospital La Fe, Valencia, Spain.
Ponce
J
J
Cano
C
C
Sopena
R
R
Hoyos
M
M
Del Val
A
A
Berenguer
J
J
D000328:Adult; D001285:Atropine / Q000494:pharmacology; D001652:Bile Ducts / Q000000981:diagnostic imaging; D002766:Cholecystokinin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D016473:Gallbladder Emptying / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists; D010277:Parasympathomimetics / Q000494:pharmacology*; D010890:Pirenzepine / Q000494:pharmacology; D011877:Radionuclide Imaging
D018727:Muscarinic Antagonists; D010277:Parasympathomimetics; D010890:Pirenzepine; D001285:Atropine; D002766:Cholecystokinin